Treating ocular surface disease: new agents in development

eating ocular surface disease: new agents in development Review (4617) Total Article Views Authors: Fahmy AM, Hardten DR Published Date April 2011 Volume 2011:5 Pages 465 - 472 DOI: http://dx.doi.org/10.2147/OPTH.S12291 Ahmad M Fahmy, David R Hardten University of Minnesota, Minneapolis, MN, USA Abstract: This paper reviews recent advances and investigation in the treatment of ocular surface pathology. There is significant investment in this area, paralleling the growing demand for more effective alternatives to current treatments. Clinicians are becoming more aware of surface pathology, yet the ability to treat the most common forms of ocular pathology are still limited to the few medications approved by the US Food and Drug Administration. Medicines and devices currently under investigation are very promising. It is absolutely critical to understand the emerging options and think of their role in the treatment paradigm.